Home›Companies›Biotech & Pharma›Biolinq

Biolinq Inc

Updated Oct 27, 2026·Latest SEC filing Mar 21, 2025·Suggest an edit

About Biolinq

Biolinq is a private company based in San Diego, California. It has reported $247,430,582 raised in eight offerings on Form D since September 2016.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 7, 2025Mar 21, 2025$90,000,000of $100.0M target45$2.0MEquityRule 506(b)Form D ↗
Dec 13, 2023Dec 26, 2023amended Sep 13, 2024$59,139,615fully sold43$1.3MDebt, Securities on exerciseRule 506(b)Form D/A ↗2 earlier filings
Sep 2, 2021Sep 17, 2021amended Jun 1, 2022$77,946,902of $105.6M target62$1.2MEquityRule 506(b)Form D/A ↗1 earlier filing
Mar 16, 2021Mar 23, 2021$5,223,811of $6.0M target21$248KDebtRule 506(b)Form D ↗
Mar 25, 2020Apr 7, 2020amended Jul 7, 2020$3,554,335of $10.0M target17$209KDebtRule 506(b)Form D/A ↗1 earlier filing
Mar 13, 2019Mar 20, 2019$3,000,000fully sold9$333KEquityRule 506(b)Form D ↗
Nov 14, 2017Nov 27, 2017$8,115,919of $13.1M target17$477KEquityRule 506(b)Form D ↗
Sep 16, 2016Sep 28, 2016$450,000of $750K target5$90,000DebtRule 506(b)Form D ↗
Total, eight offerings$247,430,582

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Biolinq's Form D filed Mar 21, 2025.

DB
David Berry
Director
DR
Derek Rapp
Director
ZB
Zina Besse
Director
RY
Richard Yang
Executive officer and director
TJ
Thad Johnson
Director
JT
Jared Tangney
Executive officer
DB
Dan Bradbury
Director
DA
David Arida
Executive officer

Earlier filings also listed Nancy Hong (director, last listed Jun 2022), Lana Ghanem (director, last listed Mar 2021), Edward Kliphuis (director, last listed Mar 2021) and Joshua Windmiller (executive officer, director and promoter, last listed Jul 2020).

Sources

  1. SECBiolinq Inc Form D/A, filed Mar 26, 2024
  2. SECBiolinq Inc Form D, filed Dec 26, 2023
  3. SECBiolinq Inc Form D, filed Sep 17, 2021
  4. SECBiolinq Inc Form D, filed Apr 7, 2020
  5. SECBiolinq Inc filing history